Liver stiffness

Biomarker3 papers1 finding

Interventions

1

Setmelanotide

downin humans1Very low certainty

1 study

Setmelanotide decreases liver stiffness in humans.
Human trialBardet-Biedl syndrome12 monthsmalesn = 1
Sequential liraglutide and setmelanotide therapy in Bardet-Biedl Syndrome: metabolic and renal outcomes in a real-world case report and literature review · Nephron · 15 Sep 2026

Setmelanotide →

Latest

16

Frontiers in MedicineReview16 Sep

A fibrosis-informed refinement of the intermediate-risk stratum for statin allocation: a liver-derived hypothesis anchored to the 2026 PREVENT-based guideline framework

Frontiers in EndocrinologyReview16 Sep

Incremental effects of SGLT2 inhibitors, GLP-1 receptor agonists, and pioglitazone in type 2 diabetes and MASLD across Asian study settings: a systematic review and meta-analysis

SGLT2 inhibitors

NephronResearch15 Sep

Sequential liraglutide and setmelanotide therapy in Bardet-Biedl Syndrome: metabolic and renal outcomes in a real-world case report and literature review

Liver InternationalHumans15 Sep

ALPS-HCC Score: A Dynamic Liver Stiffness Measurement-Based Machine Learning Model to Predict Risk of Hepatocellular Carcinoma

Hepatocellular carcinoma

Journal of Frailty, Sarcopenia and FallsHumans3 Sep

Sarcopenia in Indian Males Having Clinically Significant Liver Fibrosis in Type 2 Diabetes: A Tertiary-Centre Cross-Sectional Study to Estimate the Prevalence and Associated Factors

Frontiers in EndocrinologyHumans1 Sep

Burnout, resilience, and cardiometabolic phenotype in an academic medical faculty: an integrated cross-sectional assessment from the United Arab Emirates

Journal of Gastroenterology and HepatologyHumans28 Aug

Comparable Predictive Performance of Non-VCTE-Based Machine Learning Model for HBV-Infected Hepatocellular Carcinoma Risk

Hepatocellular carcinoma

The Journal of Clinical Endocrinology and MetabolismHumans27 Aug

Effects of Semaglutide versus Bariatric Surgery on Noninvasive Markers of Hepatic Steatosis and Fibrosis in Obesity with MASLD

International Journal of Molecular SciencesHumans27 Aug

Sarcopenia and Frailty in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Impact of Steroid Hormones

Metabolic dysfunction-associated steatotic liver disease

Diabetes Research and Clinical PracticeHuman trial25 Aug

Efficacy of dapagliflozin on hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: a pre-specified single-arm analysis from a randomized controlled trial